Information Sur Le Programme Ontarien De

Information Sur Le Programme Ontarien De

Information sur le Programme ontarien de dépistage du cancer
du col de l’utérus pour les fournisseurs de soins de santé
Documentation - Références
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.
18.
19.
20.
21.
22.
23.
24.
25.
26.
Mai 2012
Cancer Care Ontario. (Ontario Cancer Registry 2010). Prepared by Surveillance, Prevention and Cancer Control,
Cancer Care Ontario.
Sasieni P, Castanon A, Cuzick J, Snow J. Effectiveness of cervical screening with age: population based case-control study of
prospectively recorded data. BMJ 2009;339:b2968.
World Health Organization. International Agency for Research on Cancer. IARC handbooks of cancer prevention:
cervix cancer screening. Vol 10. Lyon: IARC Press; 2005.
Moscicki AB. Cervical cytology testing in teens. Curr Opin Obstet Gynecol. 2005 Oct;17(5):471–5.
Bartholomew DA. Human papillomavirus infection in adolescents: a rational approach. Adolesc Med Clin. 2004 Oct;15(3):569–95.
Moscicki AB, Shiboski S, Hills N et al. Regression of low-grade squamous intra-epithelial lesions in young women.
Lancet. 2004, 364(9446): 1678–83.
Sasieni P, Castanon A, and Cuzick J. The Impact of Cervical Screening on Young Women: A Critical Review of the Literature
2002–2009. NHS Cancer Screening Programmes Publication No 31. Sheffield; February 2010.
Arbyn M, Kyrgiou M, Simoens C, Raifu AO, Koliopoulos G, et al. Perinatal mortality and other severe adverse pregnancy outcomes
associated with treatment of cervical intraepithelial neoplasia: meta-analysis. BMJ. 2008;337:a1284. doi: 10.1136/bmj.a1284.
Bruinsma F, Lumley J, Tan J, and Quinn M. Precancerous changes in the cervix and risk of subsequent preterm birth. BJOG.
2007;114:70–80.
Kyrgiou M, Koliopoulos G, Martin-Hirsch P, Arbyn M, Prendiville W, Paraskevaidis E. Obstetric outcomes after conservative
treatment for intraepithelial or early invasive cervical lesions: systematic review and meta-analysis. Lancet. 2006;367:489–98.
Sasieni P, Castanon A, Parkin DM. How many cervical cancers are prevented by treatment of screen-detected disease in young
women? Int J Cancer. 2009; 124: 461–4.
Alberta, BC, NWT, NB and the American College of Obstetricians and Gynecologists (ACOG) have recently increased the
recommended age to initiate screening to age 21 in their screening guidelines. See Cancer Care Ontario. Ontario Cervical
Screening Program 2003-2008. Toronto: 2011.
Coldman A, Phillips N, Kan L, Matisic J, Benedet L, Towers L. Risk of invasive cervical cancer after Pap smears: the protective
effect of multiple negatives. J Med Screen. 2005;12(1):7–11.
Sawaya GF, McConnell KJ, Kulasingam SL, Lawson HW, Kerlikowske K, Melnikow J, et al. Risk of cervical cancer associated with
extending the interval between cervical-cancer screenings. N Engl J Med. 2003;349(16):1501–9.
Sasieni P, Castanon A. Call and recall cervical screening programme: Screening interval and age limits. Curr Diagn Pathol.
2006;12:114–126.
Colgan TJ, Clarke A, Hakh N, Seidenfeld A. Screening for Cervical Disease in Mature Women: Strategies for Improvement.
Cancer Cytopathol. 2002;96:195–203.
Kwong JC, Crowcroft NS, Campitelli MA, Ratnasingham S, Daneman N, Deeks SL, Manuel DG. Ontario Burden of Infectious
Disease Study Advisory Group; Ontario Burden of Infectious Disease Study (ONBOIDS): An OAHPP/ICES Report. Toronto:
Ontario Agency for Health Protection and Promotion, Institute for Clinical Evaluative Sciences; 2010.
Walboomers JM, Jacobs MV, Manos MM, Bosch FX, Kummer JA, Shah KV, et al. Human papillomavirus is a necessary cause of
invasive cervical cancer worldwide. J Pathol. 1999;189(1):12-19.
Bosch FX, Lorincz A, Muñoz N, Meijer CJ, Shah KV. The causal relation between human papillomavirus and cervical cancer.
J Clin Pathol. 2002;55(4):244-65.
Cancer Care Ontario. Insight on cancer: news and information on cervical cancer. Toronto: Canadian Cancer Society
(Ontario Division); 2005.
Cancer Care Ontario. Human Papillomavirus (HPV) Clinician Fact Sheet. May 2007.
Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England:
evaluation based on routinely collected statistics. BMJ. 1999;318:904–8.
Peto J, Gilham C, Fletcher O,Matthews FE. The cervical cancer epidemic
that screening has prevented in the UK. Lancet. 2004;364:249–56.
Cancer Care Ontario. (Ontario Cancer Registry, 2012). Prepared by Surveillance,
Prevention and Cancer Control, Cancer Care Ontario. Rates were calculated with
hysterectomy-corrected population at risk.
Cuzick J, Clavel C, Petry K, Meijer CJLM, Hoyer H, Ratnam S, et al.
Overview of the European and North American studies on HPV testing
in primary cervical cancer screening. Int J Cancer. 2006;119:1095–1101.
Cancer Care Ontario. (Ontario Cancer Registry 2010). Prepared by
Surveillance, Prevention and Cancer Control, Cancer Care Ontario.